Capital World Investors Reduces Position in Molina Healthcare, Inc. (NYSE:MOH)

Capital World Investors trimmed its stake in Molina Healthcare, Inc. (NYSE:MOH - Free Report) by 0.4% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 5,108,152 shares of the company's stock after selling 22,187 shares during the quarter. Capital World Investors owned 8.93% of Molina Healthcare worth $1,486,727,000 at the end of the most recent quarter.

Other institutional investors have also recently modified their holdings of the company. Wellington Management Group LLP increased its stake in Molina Healthcare by 7.4% during the 4th quarter. Wellington Management Group LLP now owns 2,632,232 shares of the company's stock valued at $766,111,000 after purchasing an additional 181,073 shares in the last quarter. FMR LLC raised its holdings in Molina Healthcare by 31.1% in the 4th quarter. FMR LLC now owns 1,801,113 shares of the company's stock worth $524,214,000 after acquiring an additional 427,276 shares during the last quarter. Geode Capital Management LLC boosted its stake in Molina Healthcare by 2.5% during the 4th quarter. Geode Capital Management LLC now owns 1,436,909 shares of the company's stock valued at $417,144,000 after purchasing an additional 34,992 shares during the last quarter. Invesco Ltd. increased its holdings in shares of Molina Healthcare by 28.5% in the 4th quarter. Invesco Ltd. now owns 1,327,021 shares of the company's stock worth $386,229,000 after purchasing an additional 294,180 shares in the last quarter. Finally, Dimensional Fund Advisors LP lifted its holdings in shares of Molina Healthcare by 15.3% during the fourth quarter. Dimensional Fund Advisors LP now owns 688,245 shares of the company's stock valued at $200,307,000 after purchasing an additional 91,229 shares in the last quarter. 98.50% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of equities analysts have weighed in on MOH shares. Sanford C. Bernstein started coverage on Molina Healthcare in a research report on Tuesday. They issued an "outperform" rating and a $414.00 target price for the company. Stephens restated an "equal weight" rating and issued a $345.00 target price on shares of Molina Healthcare in a report on Thursday, February 6th. UBS Group decreased their target price on shares of Molina Healthcare from $374.00 to $325.00 and set a "neutral" rating for the company in a research note on Friday, February 7th. Barclays cut their price objective on Molina Healthcare from $372.00 to $339.00 and set an "equal weight" rating for the company in a report on Friday, February 7th. Finally, Mizuho raised their target price on Molina Healthcare from $376.00 to $400.00 and gave the stock an "outperform" rating in a research report on Wednesday, April 9th. Nine equities research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. According to data from MarketBeat.com, the company currently has an average rating of "Hold" and a consensus price target of $363.62.

Molina Healthcare Price Performance

MOH stock traded down $18.79 during midday trading on Thursday, hitting $313.21. The company's stock had a trading volume of 1,062,343 shares, compared to its average volume of 777,720. The company has a quick ratio of 1.62, a current ratio of 1.62 and a debt-to-equity ratio of 0.69. Molina Healthcare, Inc. has a 12 month low of $262.32 and a 12 month high of $370.99. The company has a 50 day moving average of $317.63 and a two-hundred day moving average of $307.82. The firm has a market capitalization of $17.13 billion, a price-to-earnings ratio of 15.34, a price-to-earnings-growth ratio of 1.06 and a beta of 0.70.

Molina Healthcare (NYSE:MOH - Get Free Report) last announced its quarterly earnings results on Wednesday, April 23rd. The company reported $6.08 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $5.86 by $0.22. Molina Healthcare had a net margin of 2.90% and a return on equity of 28.13%. The company had revenue of $11.15 billion for the quarter, compared to the consensus estimate of $10.86 billion. During the same period in the previous year, the firm posted $5.73 EPS. On average, analysts expect that Molina Healthcare, Inc. will post 24.4 EPS for the current year.

Insider Buying and Selling at Molina Healthcare

In other Molina Healthcare news, Director Steven J. Orlando sold 1,000 shares of Molina Healthcare stock in a transaction on Monday, March 3rd. The shares were sold at an average price of $301.33, for a total value of $301,330.00. Following the completion of the transaction, the director now directly owns 17,375 shares of the company's stock, valued at $5,235,608.75. This trade represents a 5.44 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link. 1.10% of the stock is currently owned by company insiders.

About Molina Healthcare

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.